•
Sep 30, 2024
•
/

CRH Q3 2024 Earnings Report

Reported a robust performance driven by differentiated solutions, margin expansion, and strategic portfolio activity.

Key Takeaways

CRH reported a strong Q3 2024 performance with increased sales, profits, and margins. Total revenues reached $10.5 billion, a 4% increase, and net income was $1.4 billion, up by 5%. Adjusted EBITDA grew by 12% to $2.5 billion, with margin expansion driven by positive pricing and cost management. The company reaffirmed its FY24 guidance midpoint and anticipates favorable dynamics across key markets into 2025.

Robust performance underpinned by differentiated solutions strategy

Strong double-digit growth in Adjusted EBITDA & EPS despite adverse weather

Further margin expansion driven by positive pricing, cost management & operational efficiency

Reaffirming FY24 guidance midpoint; Net Income $3.78bn-$3.85bn; Adjusted EBITDA* $6.87bn-$6.97bn

Total Revenue
£8.09B
Previous year: £10.1B
-20.1%
EPS
£1.52
Previous year: £1.79
-15.3%
Adjusted EBITDA
£2.5B
Previous year: £2.2B
+13.6%
Adjusted EBITDA margin
23.3%
Previous year: 21.6%
+7.9%
Net income margin
13.2%
Previous year: 13%
+1.5%
Gross Profit
£2.4B
Previous year: £3.76B
-36.2%
Cash and Equivalents
£1.77B
Previous year: £5.72B
-69.1%
Free Cash Flow
£594M
Previous year: £1.23B
-51.6%
Total Assets
£29.4B
Previous year: £47.6B
-38.3%

CRH

CRH

Forward Guidance

CRH reaffirmed its guidance midpoint for 2024, reflecting continued financial strength and portfolio contributions. Positive underlying demand is expected across key end-use markets, supported by public investment. A lower interest rate environment should aid recovery in new-build residential construction.

Positive Outlook

  • Continued strength of financial performance
  • Positive underlying momentum in our business
  • Positive contribution from portfolio activity
  • Positive underlying demand across our key end-use markets
  • Significant public investment in infrastructure and re-industrialization activity

Challenges Ahead

  • Some macroeconomic uncertainties
  • Potential Q4 impairment in the range of $0.3-$0.4 billion
  • Challenging market conditions which may impact future growth prospects
  • Increased risk of impairments as a result of certain recent challenging market conditions
  • Subdued residential activity in Western Europe